Osteotec Limited (‘Osteotec’, ‘we’ or ‘our’) is making a voluntary modern slavery and human trafficking statement relating to section 54 of the Modern Slavery Act 2015.
We oppose slavery and human trafficking in all its forms and make this statement to set out the steps we have taken to ensure that there is no slavery or human trafficking in our business or in our supply chains.
About us
Osteotec is a privately owned UK-based manufacturer and distributor focused on orthopaedic extremities medical devices. We provide industry-leading, specialist orthopaedic extremities solutions and superior services to healthcare professionals that improve patient outcomes, developing a comprehensive product portfolio and partnering with leading global manufacturers. Our vision is to be the partner of choice for orthopaedic extremities through our unparalleled expertise, outstanding service and tailored solutions.
Our annual turnover is under £36 million. Although we are not required to make a modern slavery statement under section 54 of the Modern Slavery Act 2015, we are making this statement to show our commitment to ethical trading principles and to set out the steps we are taking to tackle modern slavery and human trafficking in our business and in our supply chains.
Our supply chains
The key areas in which we engage suppliers are:
Policies
As part of our commitment to combating modern slavery and human trafficking, we have maintained and completed an annual review of the following policies:
We also make sure our suppliers and distribution partners are aware of these policies and adhere to the same high standards.
We have also maintained, reviewed and, where relevant, updated our Company handbook in line with legislation and current best practice. This reflects our commitments to ensure that we respect the rights of our employees with regards to freedom of association, payment of a fair wage, working hours, equal opportunities, freedom of intimidation and a safe and healthy working environment.
Due diligence and risk assessment
As part of our efforts to monitor and reduce the risk of slavery and human trafficking occurring within our supply chains, we have adopted the following due diligence procedures:
Our procedures are designed to:
If we become aware of a failure to comply with our anti-slavery and human trafficking policy, depending on the behaviour, we may choose to terminate our relationship with our suppliers, or elect to work with the supplier to resolve such issues.
Effectiveness in combating slavery and human trafficking
We use the following key performance indicators to measure how effective we have been at ensuring that slavery and human trafficking are not taking place in any part of our business or supply chains:
Training
We invest in educating our employees to recognise the risks of modern slavery and human trafficking in our business and supply chains. Through our training programmes, employees are encouraged to identify and report any potential breaches of our anti-slavery and human trafficking policy. Employees are also educated on the benefits of using stringent measures to tackle slavery and human trafficking, as well as the consequences of failing to eradicate slavery and human trafficking from our business and supply chains.
We also require our business partners to provide training to their staff, suppliers, and providers, or provide them with training materials where they do not have any existing training programmes.
Sign-off
We will continue to build on the progress made to date. Our auditing of our suppliers and sub-contractors will continue, and data obtained from this will be used to identify areas to focus on in future years. We recognise our policies require continuing monitoring and review and we will continue to proactively identify and manage risks in our business and supply chain.
No incidents of modern slavery have been identified within our business or supply chain in financial year ending 31 December 2022.
Approval
This voluntary slavery and human trafficking statement is made in connection with section 54(1) of the Modern Slavery Act 2015, for the financial year ending 31 December 2022. It was approved by the Board on 21 March 2023.